Fierce Pharma July 16, 2024
Despite a string of high-profile losses this year, at least three major drugmakers continue to fight back against the Medicare price negotiations being rolled out under the Inflation Reduction Act.
On Friday, Johnson & Johnson and Bristol Myers Squibb filed an appeal at the U.S. Court of Appeals for the Third Circuit, arguing that the District Court judge erred in April when he tossed lawsuits by the companies questioning the constitutionality of the Inflation Reduction Act.
Two months before that decision, a Delaware federal court rejected a similar lawsuit by AstraZeneca. AstraZeneca on Monday also filed an opening appeal against that verdict before the Third Circuit.
Much of the pharmaceutical industry has been fighting against the Inflation Reduction Act (IRA)...
Today's Sponsors
Today's Sponsor